Early postoperative increase in defibrillation threshold with nonthoracotomy system in humans

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Devices

Background:

• Implantable cardioverter defibrillators (ICDs) are crucial for preventing sudden cardiac death.
• Assessing the stability of the defibrillation threshold (DFT) early after ICD implantation is vital for patient safety and device efficacy.
• Nonthoracotomy lead systems are increasingly used, necessitating an understanding of their DFT characteristics.

Purpose of the Study:

• To evaluate the stability of the defibrillation threshold (DFT) in patients early after the implantation of a multi-lead nonthoracotomy implantable cardioverter defibrillator system.
• To determine if the DFT changes in the early postoperative period and when it returns to baseline levels.

Main Methods:

• Fifteen patients with multi-lead nonthoracotomy ICD systems underwent DFT measurements at implant, 2-8 days postoperation, and 4-6 weeks later.
• DFT was defined as the lowest successful defibrillation energy, with shocks delivered in incremental steps.
• Analysis compared DFT values across the three time points.

Main Results:

• Defibrillation thresholds were significantly higher in the early postoperative period compared to at implant (22.7 +/- 7.0 J vs 16.9 +/- 3.9 J, P < 0.05).
• In patients assessed at all three periods, DFT increased postoperatively but returned to baseline levels by 4-6 weeks (16 +/- 7.1 J vs 16.4 +/- 3.9 J at implant, P = N.S.).

Conclusions:

• A transient rise in DFT is observed early after the implantation of multi-lead nonthoracotomy ICD systems.
• The DFT appears to stabilize and return to baseline within 4-6 weeks post-implantation.
• These findings have significant implications for the programming of energy output in ICD patients during the early post-implantation phase.